silver has been researched along with clindamycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corum, L; Linton, S; Okel, T; Percival, SL; Slone, W; Thomas, JG | 1 |
| Chalermchai, T; Jurairattanaporn, N; Ophaswongse, S; Udompataikul, M | 1 |
| Brown, M; Conroy, EJ; Culeddu, G; Dalton, J; Gamble, C; Griffiths, MJ; Hartley, JC; Hughes, D; Jenkinson, MD; Kearns, T; Mallucci, CL; Moitt, T; Solomon, T | 1 |
| Cooksley, CM; Feizi, S; Nepal, R; Psaltis, AJ; Vreugde, S; Wormald, PJ | 1 |
2 trial(s) available for silver and clindamycin
| Article | Year |
|---|---|
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Male; Metal Nanoparticles; Patient Satisfaction; Quality of Life; Silver; Treatment Outcome; Young Adult | 2017 |
Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Catheters; Child; Child, Preschool; Clindamycin; Cost-Benefit Analysis; Female; Humans; Hydrocephalus; Infant; Ireland; Male; Middle Aged; Rifampin; Silver; United Kingdom; Ventriculoperitoneal Shunt | 2020 |
2 other study(ies) available for silver and clindamycin
| Article | Year |
|---|---|
The efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients.
Topics: Ampicillin; Anti-Bacterial Agents; Bandages; Biofilms; Burns; Clindamycin; Culture Media; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Silver; Silver Compounds; Staphylococcus aureus | 2011 |
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Doxycycline; Gentamicins; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Staphylococcus aureus; Tobramycin | 2022 |